Delivery Order SPE2DR25D2007-SPE2DR26FM14C
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,017.90 to AmerisourceBergen Drug Corp for the supply of Terbinafine HCL 250 mg tablets (30-count). This competitively awarded, firm fixed-price contract was finalized on September 23, 2025, with an ultimate completion date of September 24, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting open competition among...
- The Defense Logistics Agency awarded a $14,842.16 delivery order to AmerisourceBergen Drug Corp for Terbinafine HCL 250 mg tablets (30-count units) under a firm fixed-price contract type. The award was made on July 23, 2025, with an ultimate completion date of July 24, 2025, and does not utilize a set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor providing critical medical supply support to federal healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $1,732.10 to AmerisourceBergen Drug Corp for the supply of Terbinafine HCL 250 mg tablets (30-count) with an ultimate completion date of November 17, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through open competition. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a delivery order valued at $10,414.44 to AmerisourceBergen Drug Corp for the supply of Terbinafine HCL 250 mg tablets in quantities of 30 units. This competitively awarded, firm fixed-price delivery order was issued on September 23, 2025, with an ultimate completion date of September 24, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting...
- The Defense Logistics Agency awarded a delivery order valued at $5,056.95 to AmerisourceBergen Drug Corp for the supply of Terbinafine HCL 250 mg tablets (30-count units). The contract is a firm fixed price delivery order with an ultimate completion date of September 4, 2025, and was awarded on September 3, 2025. This non-set-aside award was competitively awarded, reflecting AmerisourceBergen's demonstrated capability to meet federal pharmaceutical procurement requirements. The place of...
- The Defense Logistics Agency awarded a delivery order valued at $3,722.99 to AmerisourceBergen Drug Corp for the supply of Terbinafine HCL 250 mg tablets (30-count units). This is a firm fixed-price, non-set-aside contract with performance expected to be completed by August 11, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location in the same city. The delivery order represents...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Terbinafine HCL 250 mg tablets (30-count units) valued at $1,464.52 under a firm fixed-price contract. The delivery order, issued on September 26, 2025, requires completion by September 29, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This non-set-aside award was competitively awarded, reflecting the contractor's capability to meet federal...
- The Defense Logistics Agency awarded a delivery order valued at $1,255.57 to AmerisourceBergen Drug Corp for the supply of Terbinafine HCL 250 mg tablets in quantities of 30. The contract, awarded on August 19, 2025, with an ultimate completion date of August 20, 2025, utilizes firm fixed pricing with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is the prime contractor on this delivery order, which...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Terbinafine HCL 250 mg tablets (90-count units) on November 17, 2025, with a ceiling value of $1,110.08 and a firm fixed price structure. This is a non-set-aside competitive award issued as a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a delivery order valued at $1,994.33 to AmerisourceBergen Drug Corp for Terbinafine HCL 250 mg tablets (90-count) on August 22, 2025, with a completion date of August 25, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a pharmaceutical supply delivery under the Defense Logistics Agency's...
- SPE2DR25D2007Indefinite Delivery Contract
- SPE2DR25D2007-SPE2DR26FM14CDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,695.88 to AmerisourceBergen Drug Corp for the supply of Terbinafine HCL 250 mg tablets (30-count units). This is a firm fixed-price delivery order with no set-aside designation, competitively awarded and due for completion by November 18, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The award represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. This delivery order falls under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen serves military and veteran healthcare systems through this comprehensive global pharmaceutical support vehicle, which enables the company to supply a broad range of generic and brand-name medications, vaccines, and medical supplies across multiple therapeutic domains to support Department of Defense healthcare requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.7k | 11/17/25 |